Fora Capital, LLC Supernus Pharmaceuticals, Inc. Transaction History

Fora Capital, LLC

  • $789 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021
SELL
$23.54 - $31.39 $88,157 - $117,555
-3,745 Closed
0 $0
Q2 2021

Aug 16, 2021
BUY
$26.72 - $33.19 $100,066 - $124,296
3,745 New
3,745 $115 Million
Q1 2021

May 17, 2021
SELL
$24.15 - $31.45 $128,864 - $167,817
-5,336 Closed
0 $0
Q4 2020

Feb 12, 2021
BUY
$17.7 - $25.81 $94,447 - $137,722
5,336 New
5,336 $134,000

Others Institutions Holding SUPN

# of Institutions
286
Shares Held
60.7M
Call Options Held
27.7K
Put Options Held
11.3K
View Full List

About SUPERNUS PHARMACEUTICALS, INC.

SUPN Quotes by TradingView
  • Ticker SUPN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 53,495,300
  • Market Cap $2.14B
  • Description
  • Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...
More about SUPN
Track This Portfolio

Track Fora Capital, LLC Portfolio

Follow Fora Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fora Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fora Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email